Answers are grounded in this paper and cite their sources.
Findings indicate rising sensitisation to benzisothiazolinone in dermatitis patients, suggesting urgent analysis needs for consumer products.
Results confirm previous reports indicating that sensitisation to BIT is increasing in dermatitis patients in western Sweden. Analysis of products showed that concentrations of BIT can be several orders of magnitude higher than those of CMIT/MIT in products to which skin contact can be frequent and long lasting.
No takes yet. Share an insight, caveat, or question.
Farbrot et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: